This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

StemCells Inc
STEM : NASDAQ : Health Care
$1.40 0.02 | 1.10%
Today's Range: 1.35 - 1.42
Avg. Daily Volume: 1,883,300
09/17/14 - 3:24 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
STEM STEMCELLS INC 1.46 100.21 n/m 1.22 17.09
TRGT TARGACEPT INC 2.58 87.19 n/m 0.22 -95.59
CYTX CYTORI THERAPEUTICS INC 1.08 85.91 n/m 8.90 -39.36
CGIX CANCER GENETICS INC 8.78 85.14 n/m 6.50 21.10
SIGA SIGA TECHNOLOGIES INC 1.53 81.86 n/m 4.43 -37.64
BOTA BIOTA PHARMACEUTICALS INC 2.30 80.72 n/m 69.55 204.44
TROV TROVAGENE INC 5.72 124.35 n/m 0.26 -52.40
ONTX ONCONOVA THERAPEUTICS INC 5.29 114.75 n/m 3.62 512.18
FCSC FIBROCELL SCIENCE INC 2.76 112.77 n/m 0.22 9.64
ATHX ATHERSYS INC 1.37 105.88 n/m 2.64 -37.26
VICL VICAL INC 1.18 104.55 n/m 11.64 54.70
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

STEM Ind Avg S&P 500
n/m 85.52 19.69

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs